We chose the epithelial cell adhesion molecule (EpCAM) as a target moiety to deliver siRNA because this molecule is highly expressed in various epithelial cancers [32] and is an ideal target as it is highly expressed in the apical surface of tumor cells while showing basolateral expression in normal cells [33]. This evidence concerns the gene EPCAM and neoplasm.